Roche has bought partial rights to Nurix Therapeutics’ bexobrutideg in a deal worth up to $2.3bn that will see the big pharma co...
AstraZeneca has joined the long list of big pharma companies enlisting the services of Chinese biotechs, signing a deal worth up t...